Although the NAFLD status was only indirectly assessed, the authors showed improvements in NAFLD-associated biomarkers, which, in part, was attributed to increased adiponectin levels (27). The gene discussed is ADIPOQ; the disease is metabolic dysfunction-associated steatotic liver disease.